Additional file 1: Table S1. of uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R

Overview of applied primary antibodies for immunohistochemical analyses (IHC) and Western blots (WB). (DOC 53 kb)